The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow

Summary

Betahistine may provide benefit by enhancement of Cerebral Blood Flow (CBF). This placebo-controlled pharmacodynamic treatment study will primarily explore the effect of betahistine on cerebral blood flow measured by dynamic contrast-enhanced MRI imaging, in a patient population with MRI evidence of cerebrovascular compromise. Also it will be measured if CBF changes correlate with gait and cognitive changes.

Timeline

Start

2012-02

Primary completion

2013-04

Completion

2013-04

Drugs

Indications

No indication recorded.